Key facts
- This page summarizes Sally Susman's Form 4 filing for PFIZER INC (PFE).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2025, 17:38.
Sally Susman - 27 Feb 2025 Form 4 Insider Report for PFIZER INC (PFE)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- PFE
- Reported as of
- 27 Feb 2025
- Net transaction value
- +$531,162
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2025, 17:38:46 UTC
- Prior SEC filing
- 25 Feb 2025
- Next SEC filing
- 06 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shanice A. Reid, by power of atty, for Sally Susman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sally Susman filed Form 4 for PFIZER INC (PFE) on 03 Mar 2025.
Change
- Previous filing in this sequence was filed on 25 Feb 2025.
- Current net transaction value: +$531,162.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PFE
transaction
Common Stock
Options Exercise
- Transaction value
- $2,667,048
- Shares
- +85,182
- Change %
- +51%
- Price
- $31.31
- Shares after
- 250,866
- Date
- 27 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
PFE
transaction
Common Stock
Tax liability
- Transaction value
- $56,846
- Shares
- -2,178
- Change %
- -0.87%
- Price
- $26.10
- Shares after
- 248,688
- Date
- 27 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
PFE
transaction
Common Stock
Tax liability
- Transaction value
- $2,079,041
- Shares
- -79,779
- Change %
- -32%
- Price
- $26.06
- Shares after
- 168,909
- Date
- 27 Feb 2025
- Ownership
- Direct
- Footnotes
- F3, F4
PFE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 866
- Date
- 27 Feb 2025
- Ownership
- By Rule 16b-3 Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PFE
transaction
Derivative
Stock Appreciation Rights
Options Exercise
- Transaction value
- $0
- Shares
- -85,182
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 85,182
- Exercise price
- $31.31
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
Footnote F2
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Footnote F3
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Footnote F4
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.